For reference the site listed below details the process,

New Post Public Reply Private Reply Replies (2) Message Board
DMOST
For reference the site listed below details the process, procedures and qualifications need. 


https://listingcenter.nasdaqomx.com/assets/initialguide.pdf

https://listingcenter.nasdaqomx.com/assets/initialguide.pdf

There are 4 distinctive categorized markets of which a company can apply and seek acceptance under their respective requirements and criteria. They are NASDAQ GLOBAL SELECT MARKET (financial), NASDAQ GLOBAL SELECT MARKET (liquidity), NASDAQ GLOBAL SELECT (financial and liquidity) and last but not the least NASDAQ CAPITAL MARKERT (financial and liquidity).  The latter seem to be the most obtainable.

Let us explore the requirements and criteria there;

There are 3 categories of choice for which to seek acceptance and 9 define criteria assigned to each while a company must meet all requirements and criteria’s in at least 1 of 3 choices of categories.

https://listingcenter.nasdaqomx.com/assets/initialguide.pdf

You have the EQUITY STANDING , MARKET VALUE LISTED SECURITIES AND NET INCOME as your 3 categories for which to seek qualification. If you look at the site above you can see the outlined criteria for each and then began to disseminate to see if the 2 company's has an even chance of acceptance.

In my opinion, the EQUITY STANDING categories allows for the best chance of the 2 companies getting accepted although there are unknowns that neither I nor any other on this board can clarify with any certainty. But, let us take a look at just that category by itself.

EQUITY STANDING CRITERIA :

1) Equity standing of $5m-----------Unknown ------We cannot say with any certainty that combined if the 2 company;s has or does not have this minimum amount of cash to qualify. We can only assume that they do as possible investors may be on board and backing the move, and or a number of companies held shares could have been sold to obtain the necessary money’s needed to meet this qualification.

2) Market value of public held shares------15m -----As of closing Friday  market cap value  as listed, meet this requirement for acceptance.
3) Operating History----------------2 years -------There is no doubt about the amount of years they have been a business under this ticket and there for meet this requirement for acceptance.

4) Market Value of Listed Shares--------------------No Standard Qualifier Needed.

5) Net Income from Continued Operations (In latest fiscal year or 2 of the last 3 years) ------------[b ]No Standard Qualifier Needed.


6) Publicly Held Shares--------------1m----Unknown , however the assumption here is a moot point, of course they hold 1 million public shares and meet this requirement for acceptance.

7) Share Holders--------------------300-------Well this should not be a part of any debate, of course there are at the least 300 shareholders and they would meet this requirement for acceptance.

8) Market Maker------------------------3-------They are currently making a market for stock now, there is no reason to believe that this would and should not continue and there for meet this requirement for acceptance.

9) Bid Price or Closing Price respectfully----------$4, $3 dollars ---------This is probably the most sticking point of the entire qualification criteria for the merging company's and the most debatable as to how they could achieve either of these qualifiers…….but at present do not meet the requirement for acceptance . (However they could through a split when share price raised high enough to justify such for the $4 dollar bid price qualification).

But, To qualify under the $3 dollar closing price alternative, a company most have average annual revenue of 6 million for 3 years or net tangible assets of 5 million or net tangible assets of 2 million and a 3 year operating history in addition to satisfying the financial and liquidity qualifications listed above.
All of these fall under listing rules 5505(a) and 5505(b).

In conclusion this surely shows that the combined two company's does meet a great number of the criteria now and quiet possible all of the criteria listed, if we considering what little we know about the nature of the unknowns and the company’s current financial situation. 


"peace"


SK3 Group Inc. (SKTO) Stock Research Links

SKTO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 21

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading

Top 5 Most Recently Viewed Articles

Cytokinetics Faces Class Action: What You Need to Know

Updated Category News Views 175

Understanding the Class Action Lawsuit Against Cytokinetics Cytokinetics, Incorporated is currently facing a significant class action lawsuit initiated by shareholders. This legal challenge brings to light serious allegations against the Company regarding their disclosures and expectations for FDA approval of a key drug. Details of the Allegations The lawsuit asserts that...

Continue Reading
Discover the Embodied Luxury of the Champagne Specialist Course

Updated Category News Views 207

Verona Hosts the Esteemed Champagne Specialist Course The Italian Wine Academy is excited to announce a remarkable opportunity for wine enthusiasts and professionals. In Verona, for the very first time, the Academy will conduct the prestigious Comité Champagne 'Champagne Specialist' course. This unique program will be available in both English and Italian, providing an...

Continue Reading
MiniLuxe Achieves Strong Q1 2025 Growth with Strategic Focus

Updated Category News Views 378

MiniLuxe Reports Strong Financial Performance for Q1 2025 Reported figures all in U.S. Dollars MiniLuxe Holding Corp. (TSXV: MNLX) has announced exciting financial results for its first quarter of the year. This period showcased a significant 9% growth in revenue, reaching an impressive $6.1 million. Coupled with a gross profit of $2.5 million, reflective of a 12%...

Continue Reading
Transforming Shopify: AI Product Discovery for Enterprises

Updated Category News Views 141

Fredhopper's New App for Shopify Fredhopper Introduces Cutting-Edge Product Discovery Solutions The ecommerce landscape is evolving rapidly, and innovation is at the forefront. Fredhopper has launched its Product Discovery App for Shopify, bringing advanced AI-powered product search and personalized recommendations directly into the hands of enterprise merchants. This...

Continue Reading
Quantum Computing Inc. Faces Class Action Lawsuit for Shareholders

Updated Category News Views 162

Understanding the Recent Class Action Against Quantum Computing Inc. In a significant turn of events, Quantum Computing Inc. has come under legal pressure as a class action lawsuit has been filed on behalf of its shareholders. The lawsuit comes in response to allegations of misleading information that may have adversely affected investors' financial interests. Class...

Continue Reading